NFE2L2 and chronic kidney disease: In the present study, we demonstrated that the Nrf2/ARE signaling pathway is activated in HK-2 cells under high lipid conditions and that the expression of Nrf2 was also notably upregulated in the kidneys of CKD patients with hyperlipidemia.